CN205073325U - Novel stype - Google Patents

Novel stype Download PDF

Info

Publication number
CN205073325U
CN205073325U CN201520807004.0U CN201520807004U CN205073325U CN 205073325 U CN205073325 U CN 205073325U CN 201520807004 U CN201520807004 U CN 201520807004U CN 205073325 U CN205073325 U CN 205073325U
Authority
CN
China
Prior art keywords
kit
stype
novel
coated
medication layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201520807004.0U
Other languages
Chinese (zh)
Inventor
陈艳
叶明�
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201520807004.0U priority Critical patent/CN205073325U/en
Application granted granted Critical
Publication of CN205073325U publication Critical patent/CN205073325U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

The utility model relates to a novel stype, including one use medicine the layer and two pair at least ligature areas, use medicine the layer pass through the fixed wound to the patient in ligature area, use medicine the layer for multilayer structure, each in situ all can hold a medicament package. The beneficial effects of the utility model are that: the medicine and the life cycle of simple, the convenient change inside of this stype ligature are long.

Description

A kind of novel stype
Technical field
This utility model relates to the bone injury recovery stype of orthopaedics, is a kind of stype that can hold multilamellar medicated bag in more detail.
Background technology
Stype of the prior art mostly is gauze, is directly applied by medicine at wound or site of disease, then ties up medicine at wound or site of disease with gauze.But when embody rule, a lot of problem can be brought for patient, and as patient oneself can not change dressings, far again from hospital, change dressings and extremely bother; And repeatedly change dressings and also can waste a lot of stype, unhygienic, contaminated environment.
Moreover being difficult in prior art find a kind of stype being specifically designed to the Restoration stage of orthopedics patient, is very disadvantageous for patient with bone disease for this reason.
Utility model content
In order to solve the problems referred to above that prior art exists, this utility model provides a kind of novel stype, and this stype colligation is simple, be convenient for changing inner medicine and life cycle is long.
The technical scheme that this utility model adopts is: a kind of novel stype, comprises a medication layer and at least two pairs of binding straps, and described medication layer is fixed to the wound of patient by described binding strap; It is characterized in that, described medication layer is multiple structure, all can hold a kit in every one deck.
In order to increase the stability of colligation, preferred technical scheme is, the quantity of described binding strap is three right, and three pairs of binding straps all adopt magic tape colligation.
In order to increase the stability of colligation, preferred technical scheme is, the quantity of described binding strap is three right, and three pairs of binding straps all adopt the colligation of breathability adhesive tape.
Conveniently changing dressing for patient, the time of the medical personnel that reduce trouble, preferred technical scheme is, described medication layer is five layers, holds four kit altogether.
In order to adapt to the different situations of bone medicine needed for different times of patient, preferred technical scheme is, described four kit set gradually according to the direction of the near-end contacted with patient wound to far-end, are respectively the first kit, the second kit, the 3rd kit and the 4th kit.
Further preferred technical scheme is, coated in described first kit is plaster containing Radix Notoginseng Flos Carthami composition; Coated in described second kit is plaster containing Radix Dipsaci and eupolyphaga composition; Coated in described 3rd kit is plaster containing Sanguis Draxonis composition; Coated in described 4th kit is plaster containing Rhizoma Chuanxiong and Rhizoma Corydalis composition.
It should be noted that, in use, use binding strap by the colligation of medication layer on the wound of patient, now the first kit and Wound contact, wound contacts with the medicament in the first kit, when the medicament drug effect in the first kit no longer needs or dose is not enough, in medication layer, extract the first kit out, thus the pharmacy effect in the second kit is in wound; 3rd kit and the 4th kit are also same reasons, namely extract the second kit out, and the 3rd kit acts on wound, and extract the 3rd kit out, the 4th kit acts on wound; Just all kit are used, wound and bone recovery from illness.
In order to prevent the medicament moisture loss in medication layer, make drug effect more lasting, preferred technical scheme is, the top of described medication layer is provided with an antiseepage film.More preferred technical scheme is, the material of described antiseepage film is gel.
The beneficial effects of the utility model are: colligation is simple, be convenient for changing inner medicine and life cycle is long.
Accompanying drawing explanation
Fig. 1 is structural representation of the present utility model;
Fig. 2 is the A-A sectional view of Fig. 1.
In figure: 1, medication layer; 2, binding strap; 3, antiseepage film; 11, the first kit; 12, the second kit; 13, the 3rd kit; 14, the 4th kit.
Detailed description of the invention
For making the object of this utility model embodiment, technical scheme and advantage clearly, below in conjunction with the accompanying drawing in this utility model embodiment, technical scheme in this utility model embodiment is clearly and completely described, obviously, described embodiment is this utility model part embodiment, instead of whole embodiments.The element described in an accompanying drawing of the present utility model or a kind of embodiment and feature can combine with the element shown in one or more other accompanying drawing or embodiment and feature.It should be noted that for purposes of clarity, accompanying drawing and eliminate expression and the description of parts that have nothing to do with this utility model, known to persons of ordinary skill in the art and process in illustrating.Based on the embodiment in this utility model, the every other embodiment that those of ordinary skill in the art obtain under the prerequisite not paying creative work, all belongs to the scope of this utility model protection.
In the following embodiment of this utility model, the sequence number of embodiment and/or sequencing are only convenient to describe, and do not represent the quality of embodiment.The description of each embodiment is all emphasized particularly on different fields, in certain embodiment, there is no the part described in detail, can see the associated description of other embodiments.
As shown in Figure 1 and Figure 2, this utility model provides a kind of novel stype, and comprise a medication layer 1 and at least two pairs of binding straps 2, described medication layer 1 is fixed to the wound of patient by described binding strap 2; It is characterized in that, described medication layer 1 is multiple structure, all can hold a kit in every one deck.
In order to increase the stability of colligation, preferred technical scheme is, the quantity of described binding strap 2 is three right, and three pairs of binding straps 2 all adopt magic tape colligation.
In order to increase the stability of colligation, preferred technical scheme is, the quantity of described binding strap 2 is three right, and three pairs of binding straps 2 all adopt the colligation of breathability adhesive tape.
Conveniently changing dressing for patient, the time of the medical personnel that reduce trouble, preferred technical scheme is, described medication layer 1 is five layers, holds four kit altogether.
In order to adapt to the different situations of bone medicine needed for different times of patient, preferred technical scheme is, described four kit set gradually according to the direction of the near-end contacted with patient wound to far-end, are respectively the first kit 11, second kit 12, the 3rd kit 13 and the 4th kit 14.
Further preferred technical scheme is, coated in described first kit 11 is plaster containing Radix Notoginseng Flos Carthami composition; Described second medicament 12 wrap interior coated be plaster containing Radix Dipsaci and eupolyphaga composition; Coated in described 3rd kit 13 is plaster containing Sanguis Draxonis composition; Coated in described 4th kit 14 is plaster containing Rhizoma Chuanxiong and Rhizoma Corydalis composition.
It should be noted that, in use, use binding strap 2 by medication layer 1 colligation on the wound of patient, now the first kit 11 and Wound contact, wound contacts with the medicament in the first kit 11, when the medicament drug effect in the first kit 11 no longer needs or dose is not enough, in medication layer 1, take out the first kit 11, thus the pharmacy effect in the second kit 12 is in wound; 3rd kit 13 and the 4th kit 14 are also same reasons; Just all kit are used, wound and bone recovery from illness.
In order to prevent the medicament moisture loss in medication layer 1, make drug effect more lasting, preferred technical scheme is, the top of described medication layer 1 is provided with an antiseepage film 3.More preferred technical scheme is, the material of described antiseepage film 3 is gel.
This utility model is not limited to above-mentioned preferred forms; anyone can draw other various forms of products under enlightenment of the present utility model; no matter but any change is done in its shape or structure; every have identical with the application or akin technical scheme, all drops within protection domain of the present utility model.

Claims (8)

1. a novel stype, comprises a medication layer and at least two pairs of binding straps, and described medication layer is fixed to the wound of patient by described binding strap; It is characterized in that, described medication layer is multiple structure, all can hold a kit in every one deck.
2. novel stype according to claim 1, is characterized in that, the quantity of described binding strap is three right, and three pairs of binding straps all adopt magic tape colligation.
3. novel stype according to claim 1, is characterized in that, the quantity of described binding strap is three right, and three pairs of binding straps all adopt the colligation of breathability adhesive tape.
4. the novel stype according to any one of claim 1-3, is characterized in that, described medication layer is five layers, holds four kit altogether.
5. novel stype according to claim 4, is characterized in that, described four kit set gradually according to the direction of the near-end contacted with patient wound to far-end, is respectively the first kit, the second kit, the 3rd kit and the 4th kit.
6. novel stype according to claim 5, is characterized in that, coated in described first kit is plaster containing Radix Notoginseng Flos Carthami composition; Coated in described second kit is plaster containing Radix Dipsaci and eupolyphaga composition; Coated in described 3rd kit is plaster containing Sanguis Draxonis composition; Coated in described 4th kit is plaster containing Rhizoma Chuanxiong and Rhizoma Corydalis composition.
7. novel stype according to claim 1, is characterized in that, the top of described medication layer is provided with an antiseepage film.
8. novel stype according to claim 7, is characterized in that, the material of described antiseepage film is gel.
CN201520807004.0U 2015-10-16 2015-10-16 Novel stype Expired - Fee Related CN205073325U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201520807004.0U CN205073325U (en) 2015-10-16 2015-10-16 Novel stype

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201520807004.0U CN205073325U (en) 2015-10-16 2015-10-16 Novel stype

Publications (1)

Publication Number Publication Date
CN205073325U true CN205073325U (en) 2016-03-09

Family

ID=55425774

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201520807004.0U Expired - Fee Related CN205073325U (en) 2015-10-16 2015-10-16 Novel stype

Country Status (1)

Country Link
CN (1) CN205073325U (en)

Similar Documents

Publication Publication Date Title
CN104056301A (en) Traditional Chinese medicine-type hemostatic anti-inflammation liquid bandage and preparation method thereof
CN204016935U (en) A kind of medical bio magnetic dressing pastes
CN105878080A (en) Antibacterial and anti-inflammatory toothpaste
CN106137540A (en) A kind of medicinal fixed band of applying ointment or plaster
CN205073325U (en) Novel stype
CN103767825A (en) Dressing patch with replaceable drug packet
CN103230620A (en) Wet dressing towelette for emergency treatment of burns and scalds
CN203829471U (en) Drug application fixing pad
CN207605066U (en) A kind of medical dressing being freely disassembled combination
CN201299707Y (en) Medicinal patch
CN204972670U (en) Topical application of drug cervical stopper
CN102697925A (en) Traditional Chinese medicine combination for treating aural eczema
CN205054584U (en) Cardiovascular post -operation tourniquet capable of conveniently exchanging hemostasis patch
JP6747457B2 (en) Adhesive plaster
CN204484350U (en) A kind of anesthesia case
CN206342587U (en) Wrapping combined complete is fixed in first aid
CN204814419U (en) Woundplast with magnetotherapy effect
US20130267915A1 (en) Medical grade cleansing and numbing agent combination pad
CN204683693U (en) A kind of press device infected for intravenous resistant to blood
CN203988641U (en) A kind of hospital gauze
CN204147398U (en) Protector fixed by a kind of conduit
CN103230618A (en) Wet dressing towelette for emergency treatment of trauma
CN208541472U (en) A kind of anti-inflammatory gauze
CN103349689B (en) Drug for treating ulcers and sores
CN203042644U (en) Aloe wound paste

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160309

Termination date: 20161016